Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hepatic Drug Excretion: Influencing Factors01:16

Hepatic Drug Excretion: Influencing Factors

348
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
348
Hepatic Drug Excretion: Enterohepatic Cycling01:17

Hepatic Drug Excretion: Enterohepatic Cycling

2.1K
Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
2.1K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

100
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
100
Bile01:19

Bile

2.7K
Bile is a crucial bodily fluid, characterized by its yellow-green color and alkaline nature. Produced in the liver, it is transported through the common hepatic duct into either the cystic duct, leading to the gallbladder, or directly into the common bile duct. The flow of bile is regulated by the sphincter of Oddi located at the entrance of the duodenum. When this sphincter is closed, bile is redirected to the gallbladder for storage and concentration.
Bile is released when dietary fats enter...
2.7K
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

76
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
76
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

90
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
90

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Encapsulation of the novel mPGES-1 inhibitor TG554 in acetalated dextran nanoparticles.

RSC advances·2026
Same author

A Dual-Role Amphiphilic Photosensitizer: Enhancing Structural Uniformity and Optical Properties of Langmuir Monolayers.

Langmuir : the ACS journal of surfaces and colloids·2026
Same author

Strategies to overcome hepatic clearance of endogenous proteins - molecular and formulation approaches.

RSC chemical biology·2026
Same author

An Innovative Oral Ex Vivo Biofilm Model for Antimicrobial Investigations.

Pathogens (Basel, Switzerland)·2026
Same author

Scanning Photoelectrochemical Microscopy for the Investigation of Local Photocatalytic H<sub>2</sub> Evolution in Matrixed Langmuir Films.

ACS applied materials & interfaces·2026
Same author

Lithium-selective supramolecular assembly and capture by tripeptide gelators.

Chemical science·2026

Related Experiment Video

Updated: Nov 17, 2025

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis
08:56

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis

Published on: February 10, 2015

53.7K

Drug-Induced Dynamics of Bile Colloids.

Simon Hanio1, Jonas Schlauersbach1, Bettina Lenz1

  • 1Institute for Pharmacy and Food Chemistry, University of Wuerzburg, Am Hubland, 97074 Wuerzburg, Germany.

Langmuir : the ACS Journal of Surfaces and Colloids
|February 15, 2021
PubMed
Summary

Bile colloids solubilize drugs like Perphenazine. This study shows Perphenazine concentration alters colloid structure and dynamics, yet maintains drug stability.

More Related Videos

Using Multi-fluorinated Bile Acids and In Vivo Magnetic Resonance Imaging to Measure Bile Acid Transport
08:42

Using Multi-fluorinated Bile Acids and In Vivo Magnetic Resonance Imaging to Measure Bile Acid Transport

Published on: November 27, 2016

11.4K
Partial Bile Duct Ligation in the Mouse: A Controlled Model of Localized Obstructive Cholestasis
04:38

Partial Bile Duct Ligation in the Mouse: A Controlled Model of Localized Obstructive Cholestasis

Published on: March 28, 2018

16.1K

Related Experiment Videos

Last Updated: Nov 17, 2025

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis
08:56

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis

Published on: February 10, 2015

53.7K
Using Multi-fluorinated Bile Acids and In Vivo Magnetic Resonance Imaging to Measure Bile Acid Transport
08:42

Using Multi-fluorinated Bile Acids and In Vivo Magnetic Resonance Imaging to Measure Bile Acid Transport

Published on: November 27, 2016

11.4K
Partial Bile Duct Ligation in the Mouse: A Controlled Model of Localized Obstructive Cholestasis
04:38

Partial Bile Duct Ligation in the Mouse: A Controlled Model of Localized Obstructive Cholestasis

Published on: March 28, 2018

16.1K

Area of Science:

  • Biochemistry and Biophysics
  • Drug Delivery and Formulation

Background:

  • Bile colloids, composed of taurocholate and lecithin, are crucial for solubilizing hydrophobic molecules.
  • Poorly water-soluble drugs, such as Perphenazine, require effective solubilization for therapeutic efficacy.
  • Understanding drug-colloid interactions is key to optimizing drug delivery systems.

Purpose of the Study:

  • To investigate the concentration-dependent effects of Perphenazine on taurocholate/lecithin colloidal systems.
  • To elucidate the molecular mechanisms underlying Perphenazine's impact on colloid structure, arrangement, and thermodynamics.
  • To assess the ability of these natural colloids to maintain drug stability across varying concentrations.

Main Methods:

  • Analytical ultracentrifugation
  • Dynamic light scattering
  • Small-angle neutron scattering
  • Nuclear magnetic resonance spectroscopy
  • Coarse-grained molecular dynamics simulations
  • Isothermal titration calorimetry

Main Results:

  • Perphenazine concentration significantly influenced colloidal molecular arrangement, structure, and binding thermodynamics.
  • At low concentrations, Perphenazine integrated into stable, larger colloids exothermically.
  • At higher concentrations, colloids reduced in size, integration became less exothermic, and a morphological transition from vesicles to wormlike micelles occurred.
  • Despite structural changes, stable free Perphenazine levels were maintained across all tested concentrations.

Conclusions:

  • Taurocholate/lecithin colloids exhibit complex, concentration-dependent responses to Perphenazine.
  • These natural colloids demonstrate robust drug stabilization capabilities, even with significant structural dynamics.
  • Further research is needed to fully understand the molecular basis and in vivo implications of these findings.